All Type of News
The Ministry of Health and Welfare distributed letters about the safety of the SGLT-2 inhibitor type new drugs
It seems to be cautious of the dehydration side effect when the SGLT-2 inhibitor type diabetes treatment is prescribed.
The Ministry of Food and Drug Safety urgently distributed letters about the safety of the SGLT-2...
Green Cross received a KRW 81 billion order of varicella vaccines
Last year, Green Cross, that recorded KRW 200 million exports for the first time in the domestic pharmaceutical industry,made a splendid achievement to export the largest amount of varicella vaccines to an internation...
What is the reason to delay launching the SGLT-2 inhibitor type diabetes treatment?
Boehringer Ingelheim and Lilly decided to delay launching the diabetes treatment ‘Jardiance’ in the market.
According to the industry concerned on the 15th, Boehringer Ingelheim and Lilly (hereinafter referring to BI...
GSK registered the most patents last year
It is known that the number of cases registered in the Green List (a catalogue for pharmaceutical product patents) were 182 in the last year and 1618 in total.
The company with the most registered patents was turned ...
The average wage of medical doctors was KRW 100 million… the fewer sickbeds, the higher wage
It is known that the average wage of domestic medical doctors was approximately KRW 110 million per a person. The average wage of specialists was approximately KRW 120 million per a person.
According to the 2013 Hosp...
Caused by the Guillotine, the conflict of medical and oriental medicine industriesmay lead to the Korean Medicine Expulsion Campaign
As the Association of Korean Medicine claimed the right of using medicalequipment, like CT, MRI, ultrasonic waves and endoscopy, for oriental doctors, the medical industry is showing outrageous responds questioning “T...
BMS won the nullity trial for the Baraclude’s patent
BMS Pharmaceutical Korea announced on the 13th that it won a nullity trial for the substance patent of the hepatitis type B treatment ‘Baraclude (generic name: entecavir)’.
Eun-young Kim, CEO of BMS Pharmaceutical Ko...
Top listed pharmaceutical companies have engaged in the ‘speed battle’over the next generation antiulcer drug
CJ Healthcare, Yuhan Corporation and Dawwoong Pharmaceutical are engaged in a speed battle over the P-CAB-type (Potassium Competitive Acid Blocker) drug, receivingattention as the next generation antiulcer drug.
The ...
Brilinta has been approved to crush to administer for the first time as an antiplatelet drug
The AstraZeneca’s ‘Brilinta (generic name: ticagrelor)’ has been approved to administer in a crushed form by the Ministry of Food andDrug Safety for the first time as an antiplatelet drug.
It is observed that the app...
The COX-2 inhibitor market has gotten heated up with launched of generics and new drugs
Pfizer has made movements to prevent the ‘Sales Cliff’ phenomenon in which sales decline after the patent expiration of the selective COX-2 inhibitor ‘Celebrex (generic name: celecoxib)’ that will be expired in June t...
